Literature DB >> 24312807

Affinity Purification of Tumor Necrosis Factor-α Expressed in Raji Cells by Produced scFv Antibody Coupled CNBr-Activated Sepharose.

Jalal Abdolalizadeh1, Jafar Majidi Zolbanin, Mohammad Nouri, Behzad Baradaran, Aliakbar Movassaghpour, Safar Farajnia, Yadollah Omidi.   

Abstract

PURPOSE: Recombinant tumor necrosis factor-alpha (TNF-α) has been utilized as an antineoplastic agent for the treatment of patients with melanoma and sarcoma. It targets tumor cell antigens by impressing tumor-associated vessels. Protein purification with affinity chromatography has been widely used in the downstream processing of pharmaceutical-grade proteins.
METHODS: In this study, we examined the potential of our produced anti-TNF-α scFv fragments for purification of TNF-α produced by Raji cells. The Raji cells were induced by lipopolysaccharides (LPS) to express TNF-α. Western blotting and Fluorescence-activated cell sorting (FACS) flow cytometry analyses were used to evaluate the TNF-α expression. The anti-TNF-α scFv selected from antibody phage display library was coupled to CNBr-activated sepharose 4B beads used for affinity purification of expressed TNF-α and the purity of the protein was assessed by SDS-PAGE.
RESULTS: Western blot and FACS flow cytometry analyses showed the successful expression of TNF-α with Raji cells. SDS-PAGE analysis showed the performance of scFv for purification of TNF-α protein with purity over 95%.
CONCLUSION: These findings confirm not only the potential of the produced scFv antibody fragments but also this highly pure recombinant TNF-α protein can be applied for various in vitro and in vivo applications.

Entities:  

Keywords:  Affinity Purification; LPS; Monoclonal antibody; TNF-α expression

Year:  2013        PMID: 24312807      PMCID: PMC3846060          DOI: 10.5681/apb.2013.004

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  23 in total

1.  Modified His-tag fusion vector for enhanced protein purification by immobilized metal affinity chromatography.

Authors:  Sinéad T Loughran; Noeleen B Loughran; Barry J Ryan; Brendan N D'Souza; Dermot Walls
Journal:  Anal Biochem       Date:  2006-06-02       Impact factor: 3.365

Review 2.  Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins.

Authors:  José Arnau; Conni Lauritzen; Gitte E Petersen; John Pedersen
Journal:  Protein Expr Purif       Date:  2005-12-28       Impact factor: 1.650

3.  [Preparations of the specific antibodies against exon 2 and exon 3 of human tau protein].

Authors:  Cao Chen; Gui-rong Wang; Qi Shi; Bao-yun Zhang; Guo-yong Mei; Yuan Li; Xin Wang; Rui-min Zhou; Jun Han; Yu-jun Zhao; Xiao-ping Dong
Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi       Date:  2009-04

4.  Purification of recombinant proteins from mammalian cell culture using a generic double-affinity chromatography scheme.

Authors:  Brian Cass; Phuong Lan Pham; Amine Kamen; Yves Durocher
Journal:  Protein Expr Purif       Date:  2005-03       Impact factor: 1.650

Review 5.  Recombinant human tumor necrosis factor: an efficient agent for cancer treatment.

Authors:  F J Lejeune; C Rüegg
Journal:  Bull Cancer       Date:  2006-08       Impact factor: 1.276

6.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

7.  [Preparation, purification and identification of the polyclonal antibody of PHD finger protein 8].

Authors:  Rong Cai; Xin Ye
Journal:  Sheng Wu Gong Cheng Xue Bao       Date:  2010-03

8.  Downstream characterization of anti-TNF-α single chain variable fragment antibodies.

Authors:  Jalal Abdolalizadeh; Mohammad Nouri; Jafar Majidi Zolbanin; Behzad Baradaran; Abolfazl Barzegari; Yadollah Omidi
Journal:  Hum Antibodies       Date:  2012

Review 9.  Technology insight: Utility of TNF-alpha-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities.

Authors:  Dirk J Grünhagen; Johannes H W de Wilt; Timo L M ten Hagen; Alexander M M Eggermont
Journal:  Nat Clin Pract Oncol       Date:  2006-02

10.  Strategies for improving the anti-neoplastic activity of TNF by tumor targeting.

Authors:  Angelo Corti
Journal:  Methods Mol Med       Date:  2004
View more
  2 in total

Review 1.  Overview of Albumin and Its Purification Methods.

Authors:  Ramin Raoufinia; Ali Mota; Neda Keyhanvar; Fatemeh Safari; Sara Shamekhi; Jalal Abdolalizadeh
Journal:  Adv Pharm Bull       Date:  2016-12-22

2.  Purification and Characterization of Bovine Serum Albumin Using Chromatographic Method.

Authors:  Sanaz Balkani; Sara Shamekhi; Ramin Raoufinia; Reza Parvan; Jalal Abdolalizadeh
Journal:  Adv Pharm Bull       Date:  2016-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.